Cargando…

Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System

Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (MDA5(+) DM) is typically characterized by cutaneous manifestations, amyopathic or hypomyopathic muscle involvement, and a high incidence of rapid progressive interstitial lung disease (RP-ILD). However, the exact etio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Huifang, Yang, Hang, Liu, Yi, Yan, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818857/ https://www.ncbi.nlm.nih.gov/pubmed/35141258 http://dx.doi.org/10.3389/fmed.2021.833114

Ejemplares similares

Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
por: Lv, Xia, et al.
Publicado: (2022)

A Matrix Prediction Model for the 6-Month Mortality Risk in Patients With Anti-Melanoma Differentiation-Associated Protein-5-Positive Dermatomyositis
por: Ouyang, Zhi-Ming, et al.
Publicado: (2022)

Editorial: Anti-MDA5-Positive Dermatomyositis
por: Gono, Takahisa, et al.
Publicado: (2022)

Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis
por: Weng, Chenghua, et al.
Publicado: (2022)

Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud
por: Yang, Jinming, et al.
Publicado: (2022)

Association of Cytomegalovirus Infection With Anti-MDA5 Antibody-Positive Dermatomyositis: A Prospective Cohort Study
por: Huang, Linlin, et al.
Publicado: (2021)

Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients
por: Qian, Jinjing, et al.
Publicado: (2023)

Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment
por: Pinotti, Caitlan S., et al.
Publicado: (2023)

Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome
por: Ding, Yukang, et al.
Publicado: (2022)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
por: Zhou, Shuang, et al.
Publicado: (2022)

Anti-transcription Intermediary Factor1γ-antibody-positive Dermatomyositis Complicated by Dysphagia
por: Kurushima, Shota, et al.
Publicado: (2017)

Fulminant Course of Neuromyelitis Optica in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis: A Case Report
por: Kang, You-Ri, et al.
Publicado: (2020)

Management of Anti-melanoma Differentiation-Associated Gene 5 (Anti-MDA5)-Positive Dermatomyositis in an Acute Rehabilitation Center: A Case Report
por: Medina, Roi F, et al.
Publicado: (2022)

Seasonal Effect on Disease Onset and Presentation in Anti-MDA5 Positive Dermatomyositis
por: So, Ho, et al.
Publicado: (2022)

Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
por: Isono, Taisuke, et al.
Publicado: (2021)

Radiological Characteristics of Patients With Anti-MDA5–Antibody-Positive Dermatomyositis in (18)F-FDG PET/CT: A Pilot Study
por: Cao, Heng, et al.
Publicado: (2021)

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
por: Nombel, Anaïs, et al.
Publicado: (2021)

Fatal and extensive multiorgan hemorrhages in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: An autopsy case report
por: Watanabe, Tsuyoshi, et al.
Publicado: (2020)

Type I interferon pathway in adult and juvenile dermatomyositis
por: Baechler, Emily C, et al.
Publicado: (2011)

Spontaneous Intramuscular Hemorrhage in Anti-MDA5 Positive Dermatomyositis: A Case Series and Literature Review
por: Xu, Zhangling, et al.
Publicado: (2022)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

The synchronized gene expression of retrotransposons and type I interferon in dermatomyositis
por: Kuriyama, Yuko, et al.
Publicado: (2020)

Anti-melanoma differentiation-associated gene 5 and anti-Ro52 antibody-dual positive dermatomyositis accompanied by rapidly lung disease: Three case reports
por: Ye, Wen-Zheng, et al.
Publicado: (2023)

Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis
por: Yamamoto, Shotaro, et al.
Publicado: (2021)

Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease
por: Gui, Xianhua, et al.
Publicado: (2022)

A Computed Tomography Radiomics-Based Prediction Model on Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis
por: Xu, Wenwen, et al.
Publicado: (2021)

Anti–melanoma differentiation–associated gene 5 dermatomyositis complicated by myopericarditis
por: Milani-Nejad, Nima, et al.
Publicado: (2019)

An unusual anti–melanoma differentiation–associated protein 5 amyopathic dermatomyositis
por: Barailler, Héloïse, et al.
Publicado: (2019)

Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan
por: Muro, Yoshinao, et al.
Publicado: (2011)

Presence and Implications of Anti‐Angiotensin Converting Enzyme‐2 Immunoglobulin M Antibodies in Anti‐Melanoma‐Differentiation‐Associated 5 Dermatomyositis
por: Mecoli, Christopher A., et al.
Publicado: (2022)

Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema
por: Chen, Lauren, et al.
Publicado: (2020)

Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
por: Bharali, Dhruba J, et al.
Publicado: (2009)

Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis
por: Chen, Cuihong, et al.
Publicado: (2021)

Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis
por: Guo, Xiang, et al.
Publicado: (2014)

Type I interferon, anti-interferon antibodies, and COVID-19
por: Calabrese, Leonard H, et al.
Publicado: (2021)

Anti-citrullinated Protein Antibody Generation, Pathogenesis, Clinical Application, and Prospects
por: Liu, Jiaxi, et al.
Publicado: (2022)

Interstitial Lung Disease-Complicated Anti-MDA5 Antibody in Clinically Amyopathic Dermatomyositis Patients: Report of Two Cases With Distinct Clinical Features
por: Pacot, Laurence, et al.
Publicado: (2020)

Clinical features and prognostic factors of anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis with rapidly progressive interstitial lung disease in Chinese patients
por: Lian, Li, et al.
Publicado: (2023)

Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
por: Harada, Yumi, et al.
Publicado: (2022)

Imaging in dermatomyositis in adults and children
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tkbsq70tspa7epkoc8cnkchfsj